tiprankstipranks
Analyst Profile
Followed by 32 other investors
.
Vijay Kumar

Vijay Kumar

Evercore ISI
Wall Street Analyst
Ranked #3,446 out of 8,047 Analysts on TipRanks (#7,292 out of 21,521 overall experts)

Success Rate

56%
60 out of 107 Profitable Transactions

Average Return

2.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Vijay Kumar's ratings since 2010 and opened each position for the duration of 1 Year:
56.07% of your transactions would have been profitable with an average return of 2.1%

Stock Rating Distribution

168Ratings
68.45% Buy
24.40% Hold
7.14% Sell
Distribution of Vijay Kumar's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
NovoCure Ltd.
(NVCR)
Rating Type:Buy
Dates:Jul 16, 2018 - Jul 16, 2019
Gain:93.30%
The most profitable rating made by Vijay Kumar

Vijay Kumar's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Medco
Buy
Reiterated
100%
+6.25%
2
St Jude Medical
Hold
Reiterated
0.00%
2
Cepheid
Hold
Upgraded
50%
+14.60%
5
CR Bard
Buy
Initiated
100%
+43.40%
1
Boston Scientific
Buy
Upgraded
$42.50
(0.40% Upside)
80%
+15.22%
5
Varian Medical Systems
Hold
Upgraded
33%
-24.80%
5
Twist Bioscience
Hold
Downgraded
$140.00
(164.30% Upside)
0.00%
1
Ortho Clinical Diagnostics Holdings
Buy
Upgraded
100%
+14.17%
4
Medtronic
Buy
Reiterated
$122.00
(28.66% Upside)
63%
+7.05%
9
Avantor
Buy
Reiterated
$42.00
(47.06% Upside)
0%
-22.20%
3
List of latest recommendations made by Vijay Kumar. Click to expand and see Vijay Kumar's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More